Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer

Tumor cells shed DNA into the plasma. “Liquid biopsy” analysis of mutations or other genomic alterations in circulating cell-free DNA (cfDNA) may provide us with a tool to detect minimal residual cancer, comprehensively profile the genomic tumor landscape in search of druggable targets, and monitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Paschold, Lisa, Binder, Mascha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947276/
https://www.ncbi.nlm.nih.gov/pubmed/35323320
http://dx.doi.org/10.3390/curroncol29030120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947276/
https://www.ncbi.nlm.nih.gov/pubmed/35323320
http://dx.doi.org/10.3390/curroncol29030120

Ejemplares similares